Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s451668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Congcong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shangdong, 264000, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms, Acrylamides, Aminoquinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shangdong, 264000, People's Republic of China.
- Department Brest Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shangdong, 264000, People's Republic of China.
ORCID-Profile: Jinyu Xiang, Jing Li
Zitieren
APA
Wang, C., Xiang, J., Zhang, Q., Li, J., Liu, Y., & Liu, J. (2024). Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s451668
Vancouver
Wang C, Xiang J, Zhang Q, Li J, Liu Y, Liu J. Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s451668
BibTeX
@article{Wang2024,
author = {Wang, Congcong and Xiang, Jinyu and Zhang, Qingyu and Li, Jing and Liu, Yanqing and Liu, Jiannan},
title = {Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s451668}
}
EUVIMED